[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-110814-en":3,"doc-seo-110814-105":30,"detail-sidebar-cat-0-en-105":91},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"doc_content":15,"file_id":16,"file_url":17,"file_type":18,"file_size":19,"view_count":20,"is_deleted":4,"is_public":21,"is_downloadable":21,"audit_status":21,"page_count":21,"language":22,"language_code":23,"site_id":24,"html_lang":23,"table_of_contents":25,"faqs":26,"seo_title":27,"seo_description":14,"update_tm":28,"read_time":29},110814,2336475104362,"Eden","https://ap-avatar.wpscdn.com/avatar/22000c4c46a41b752dd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786595829695023868",8,"Research & Report","Ethiopia - COVID-19 Emergency Response Projects Additional Financing - Chair’s Summary","Executive Directors approved a restructuring and additional IDA grant for the Ethiopia COVID-19 Emergency Response Project, and a restructuring with an additional loan for the Tunisia COVID-19 Response Project. Directors approved modifications to the vaccine-purchase eligibility threshold, including approvals by stringent regulatory authorities or WHO Emergency Use Listing. They emphasized equitable, rapid vaccine rollout aligned with WHO guidance, strong collaboration with COVAX and MDBs, and close work with partners and humanitarian actors. They also called for enhanced supervision, monitoring, risk mitigation, community communications, and attention to vaccine hesitancy and readiness constraints, especially in FCV countries.","Public Disclosure Authorized Public Disclosure Authorized  \nRepublic of Tunisia  \nTunisia COVID-19 Response Project (P175875)  \nThe Federal Democratic Republic of Ethiopia  \nAdditional Financing for Ethiopia COVID-19 Emergency Response Project (P175853)  \nChair’s Summary*  \nMarch 26, 2021  \nExecutive Directors approved (i) a restructuring and an additional IDA grant in the amount of SDR 143.7 million (US$ 207 million equivalent) for the Ethiopia COVID-19 Emergency Response Project; and (ii) a restructuring and an additional loan in the amount of EUR 82.5 million (US$100 million equivalent) for the Tunisia COVID-19 Response Project; all on the terms and conditions set out in the President’s Memoranda.  \nDirectors approved the modification to the threshold for eligibility of IBRD/IDA resources in vaccine purchase for these two projects which requires that either: (i) the vaccine has been approved by three Stringent Regulatory Authorities (including for Emergency Use Authorization) in two Regions; or (ii) the vaccine has received WHO Emergency Use Listing, and has been produced under a licensing or similar arrangement from a manufacturer of a parent/bioequivalent vaccine that has received a Stringent Regulatory Authority approval (including Emergency Use Authorization) . They welcomed Management’s plans to soon propose a modification to the threshold for eligibility for vaccine purchases for Board approval. Management will continue bringing vaccines projects to the Board for approval until a general modification of the vaccines’ eligibility criteria is approved.  \nDirectors noted that the two operations are an important contribution to the response to the pandemic and would be supportive of economic recovery. They asked the Bank to leverage its comparative advantage, commending the good collaboration with COVAX and MDBs and stressed the importance of working closely with key partners and humanitarian actors, and alignment with the strategies of the two governments. They welcomed the deployment of vaccines in line with WHO guidelines and emphasized the urgency to accelerate an equitable vaccine roll-out to contain the pandemic, with due regard to prioritized and most in-need situations as well as vulnerable groups, including refugees. Directors stressed that strengthening country health systems overall will be imperative in the long run.  \nFinally, Directors called for enhanced supervision and monitoring mechanisms, sharing lessons from experience, as well as mitigation measures to manage risks and to ensure high quality implementation, especially in FCV countries. They asked that attention be paid to communications with communities, and the constraints related to vaccine hesitancy, capacity, fragility, governance, financial, technical, and legal matters, as well as other readiness issues, to support effective delivery of vaccines and to better manage vaccine roll-out. Directors requested updates on the implementation of vaccine projects, which Management will provide as part of vaccine updates and Operations Quarterly Updates.  \n*This Summary is not an approved record.","cbCaidVU9KeCDL7N","https://ap.wps.com/l/cbCaidVU9KeCDL7N","pdf",206027,6,1,"English","en",105,"# Executive Directors’ approvals\n## Vaccine eligibility threshold and next steps\n## Support for response, economic recovery, and equitable rollout\n## Supervision, monitoring, risk mitigation, and communications\n## Note on the summary","[{\"question\":\"What approvals were granted by the Executive Directors for the Ethiopia and Tunisia COVID-19 projects?\",\"answer\":\"Directors approved Ethiopia’s restructuring with an additional IDA grant and Tunisia’s restructuring with an additional loan, based on the terms in the President’s Memoranda.\"},{\"question\":\"How was the vaccine purchase eligibility threshold modified?\",\"answer\":\"Eligibility requires either approval by three Stringent Regulatory Authorities across two Regions (including Emergency Use Authorization) or WHO Emergency Use Listing with production under a licensing arrangement tied to a parent/bioequivalent vaccine approved by a Stringent Regulatory Authority (including Emergency Use Authorization).\"},{\"question\":\"What priorities did Directors emphasize for implementing the vaccine rollout?\",\"answer\":\"They emphasized urgency for an equitable rollout in prioritized and most in-need situations, attention to vulnerable groups such as refugees, stronger country health systems, and enhanced supervision, monitoring, risk mitigation, and community communications.\"}]","Ethiopia - COVID-19 Emergency Response Projects Additional Financing - Chair’s Summary | PDF",1784487223,3,{"code":4,"msg":31,"data":32},"ok",{"site_id":24,"language":23,"slug":33,"title":13,"keywords":34,"description":14,"schema_data":35,"social_meta":86,"head_meta":88,"extra_data":90,"updated_unix":28},"ethiopia-covid-19-emergency-response-projects-additional-financing-chairs-summary","",{"@graph":36,"@context":85},[37,53,68],{"@type":38,"itemListElement":39},"BreadcrumbList",[40,44,48,50],{"item":41,"name":42,"@type":43,"position":21},"https://docshare.wps.com","Home","ListItem",{"item":45,"name":46,"@type":43,"position":47},"https://docshare.wps.com/document/","Document",2,{"item":49,"name":12,"@type":43,"position":29},"https://docshare.wps.com/document/research-report/",{"item":51,"name":13,"@type":43,"position":52},"https://docshare.wps.com/document/ethiopia-covid-19-emergency-response-projects-additional-financing-chairs-summary/110814/",4,{"url":51,"name":13,"@type":54,"author":55,"headline":13,"publisher":57,"fileFormat":60,"inLanguage":23,"description":14,"dateModified":61,"datePublished":62,"encodingFormat":60,"isAccessibleForFree":63,"interactionStatistic":64},"DigitalDocument",{"name":9,"@type":56},"Person",{"url":41,"name":58,"@type":59},"DocShare","Organization","application/pdf","2026-08-22","2026-07-19",true,{"@type":65,"interactionType":66,"userInteractionCount":20},"InteractionCounter",{"@type":67},"ViewAction",{"@type":69,"mainEntity":70},"FAQPage",[71,77,81],{"name":72,"@type":73,"acceptedAnswer":74},"What approvals were granted by the Executive Directors for the Ethiopia and Tunisia COVID-19 projects?","Question",{"text":75,"@type":76},"Directors approved Ethiopia’s restructuring with an additional IDA grant and Tunisia’s restructuring with an additional loan, based on the terms in the President’s Memoranda.","Answer",{"name":78,"@type":73,"acceptedAnswer":79},"How was the vaccine purchase eligibility threshold modified?",{"text":80,"@type":76},"Eligibility requires either approval by three Stringent Regulatory Authorities across two Regions (including Emergency Use Authorization) or WHO Emergency Use Listing with production under a licensing arrangement tied to a parent/bioequivalent vaccine approved by a Stringent Regulatory Authority (including Emergency Use Authorization).",{"name":82,"@type":73,"acceptedAnswer":83},"What priorities did Directors emphasize for implementing the vaccine rollout?",{"text":84,"@type":76},"They emphasized urgency for an equitable rollout in prioritized and most in-need situations, attention to vulnerable groups such as refugees, stronger country health systems, and enhanced supervision, monitoring, risk mitigation, and community communications.","https://schema.org",{"og:url":51,"og:type":87,"og:title":13,"og:site_name":58,"og:description":14},"article",{"robots":89,"canonical":51},"index,follow",{"doc_id":7,"site_id":24},{"code":4,"msg":5,"data":92},[93,97,101,105,110,114,119,122,127,130,134],{"id":21,"doc_module":4,"doc_module_name":46,"category_name":94,"show_sort_weight":95,"slug":96},"Story & Novel",90,"story-novel",{"id":47,"doc_module":4,"doc_module_name":46,"category_name":98,"show_sort_weight":99,"slug":100},"Literature",80,"literature",{"id":52,"doc_module":4,"doc_module_name":46,"category_name":102,"show_sort_weight":103,"slug":104},"Exam",70,"exam",{"id":106,"doc_module":4,"doc_module_name":46,"category_name":107,"show_sort_weight":108,"slug":109},5,"Comic",60,"comic",{"id":20,"doc_module":4,"doc_module_name":46,"category_name":111,"show_sort_weight":112,"slug":113},"Technology",50,"technology",{"id":115,"doc_module":4,"doc_module_name":46,"category_name":116,"show_sort_weight":117,"slug":118},7,"Healthcare",40,"healthcare",{"id":11,"doc_module":4,"doc_module_name":46,"category_name":12,"show_sort_weight":120,"slug":121},30,"research-report",{"id":123,"doc_module":4,"doc_module_name":46,"category_name":124,"show_sort_weight":125,"slug":126},9,"Religion & Spirituality",20,"religion-spirituality",{"id":125,"doc_module":4,"doc_module_name":46,"category_name":128,"show_sort_weight":125,"slug":129},"World Cup","world-cup",{"id":131,"doc_module":4,"doc_module_name":46,"category_name":132,"show_sort_weight":131,"slug":133},10,"Lifestyle","lifestyle",{"id":135,"doc_module":4,"doc_module_name":46,"category_name":136,"show_sort_weight":106,"slug":137},19,"General","general"]